Lipitor

Atorvastatin, the active ingredient in Lipitor, is a HMG‑CoA reductase inhibitor presented as an oral tablet for systemic use. It lowers elevated cholesterol and triglyceride levels and is prescribed for adults with primary hypercholesterolemia, mixed dyslipidemia, familial hypercholesterolemia, and for cardiovascular disease prevention.

GNH USA supplies Lipitor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across EU and global markets, and provides comprehensive documentation and reliable logistics to ensure timely delivery.

Atorvastatin acts on lipid metabolism to improve blood lipid profiles and reduce cardiovascular risk. - Hypercholesterolemia: lowers LDL‑cholesterol to reduce cardiovascular risk. - Mixed dyslipidemia: decreases total cholesterol, LDL‑C and triglycerides while modestly raising HDL‑C. - Familial hypercholesterolemia: provides additional LDL‑C reduction when diet and lifestyle are insufficient. - Primary and secondary prevention of cardiovascular disease: helps prevent myocardial infarction, stroke and revascularisation procedures.

Atorvastatin is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Muscle pain or weakness - Headache - Nausea or abdominal discomfort - Elevated liver enzymes

Serious or Rare Side Effects: - Rhabdomyolysis leading to renal failure - Severe hepatic injury or hepatitis - Allergic reactions such as angioedema or anaphylaxis

Before initiating therapy with Lipitor, several precautionary measures should be considered. - Liver function assessment: obtain baseline hepatic enzymes and monitor periodically. - Renal impairment: adjust monitoring in patients with severe kidney disease. - Concomitant medications: review for drugs that increase statin exposure, such as strong CYP3A4 inhibitors. - Pregnancy and lactation: avoid use unless benefits clearly outweigh risks. - Muscle disorders: educate patients to report unexplained muscle pain or weakness promptly. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Atorvastatin may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, HIV protease inhibitors): may cause dangerous increases in atorvastatin levels. - Gemfibrozil or other fibrates: heightened risk of myopathy and rhabdomyolysis. - Cyclosporine or tacrolimus: significant elevation of statin concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance anticoagulant effect; monitor INR. - Digoxin: possible increase in serum digoxin concentrations; check levels. - Niacin (high dose): may increase risk of muscle toxicity; observe for symptoms.